About DIATECH DIABETES, INC
DEKA Research Development has acquired Diatech Diabetes' core assets and intellectual property, focusing on improving insulin infusion safety. The company develops advanced medical technologies, including the FDA-cleared twiist® insulin pump.
Development of automated insulin delivery systemsCreation of FDA-cleared medical devicesIntegration of SmartFusion® software for monitoring medication delivery failuresAdvanced insulin dosing and drug infusion technologies
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to DIATECH DIABETES, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.